156 related articles for article (PubMed ID: 2204345)
1. Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus.
Keller RJ
J Autoimmun; 1990 Jun; 3(3):321-7. PubMed ID: 2204345
[TBL] [Abstract][Full Text] [Related]
2. T-lymphocyte changes linked to autoantibodies. Association of insulin autoantibodies with CD4+CD45R+ lymphocyte subpopulation in prediabetic subjects.
Faustman D; Schoenfeld D; Ziegler R
Diabetes; 1991 May; 40(5):590-7. PubMed ID: 1827080
[TBL] [Abstract][Full Text] [Related]
3. Cellular immune response to diverse islet cell antigens in IDDM.
Durinovic-Bellò I; Hummel M; Ziegler AG
Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
[TBL] [Abstract][Full Text] [Related]
4. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
[TBL] [Abstract][Full Text] [Related]
5. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes.
Harrison LC; De Aizpurua H; Loudovaris T; Campbell IL; Cebon JS; Tait BD; Colman PG
Diabetes; 1991 Sep; 40(9):1128-33. PubMed ID: 1936620
[TBL] [Abstract][Full Text] [Related]
6. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM
Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129
[TBL] [Abstract][Full Text] [Related]
7. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
8. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
Harrison LC; Chu SX; DeAizpurua HJ; Graham M; Honeyman MC; Colman PG
J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
[TBL] [Abstract][Full Text] [Related]
9. Occult CD45 T cell developmental defect in type 1 diabetes.
Faustman DL
Diabete Metab; 1993; 19(5):446-57. PubMed ID: 8056125
[TBL] [Abstract][Full Text] [Related]
10. Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes.
Brooks-Worrell B; Gersuk VH; Greenbaum C; Palmer JP
J Immunol; 2001 Apr; 166(8):5265-70. PubMed ID: 11290812
[TBL] [Abstract][Full Text] [Related]
11. Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.
Tun RY; Peakman M; Alviggi L; Hussain MJ; Lo SS; Shattock M; Pyke DA; Bottazzo GF; Vergani D; Leslie RD
BMJ; 1994 Apr; 308(6936):1063-8. PubMed ID: 8173426
[TBL] [Abstract][Full Text] [Related]
12. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
Schloot NC; Roep BO; Wegmann D; Yu L; Chase HP; Wang T; Eisenbarth GS
Diabetologia; 1997 May; 40(5):564-72. PubMed ID: 9165225
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
Baekkeskov S
Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
[TBL] [Abstract][Full Text] [Related]
14. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
Dotta F; Eisenbarth GS
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
[TBL] [Abstract][Full Text] [Related]
15. Insulin autoantibodies as determined by competitive radiobinding assay are positively correlated with impaired beta-cell function--the Ulm-Frankfurt Population Study.
Yassin N; Seissler J; Glück M; Boehm BO; Heinze E; Pfeiffer EF; Scherbaum WA
Klin Wochenschr; 1991 Oct; 69(16):736-41. PubMed ID: 1762378
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes.
Dotta F; Gianani R; Previti M; Lenti L; Dionisi S; D'Erme M; Eisenbarth GS; Di Mario U
Diabetes; 1996 Sep; 45(9):1193-6. PubMed ID: 8772721
[TBL] [Abstract][Full Text] [Related]
17. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes.
Atkinson MA; Maclaren NK; Scharp DW; Lacy PE; Riley WJ
Lancet; 1990 Jun; 335(8702):1357-60. PubMed ID: 1971659
[TBL] [Abstract][Full Text] [Related]
18. Islet autoantibodies in cord blood from patients who developed type 1 diabetes mellitus at 15-30 years of age.
Elfving AM; Lindberg BA; Nyström L; Sundkvist G; Lernmark A; Ivarsson SA;
Autoimmunity; 2003 Jun; 36(4):227-31. PubMed ID: 14563016
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
[TBL] [Abstract][Full Text] [Related]
20. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
